Short answer
Edwards Lifesciences (EW) filed an 8-K current report with the SEC on August 28, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers). Donald E. Bobo Jr. plans to retire by mid-2027 from Corporate Vice President, Strategy and Corporate Development.
Edwards Lifesciences 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.02 · Departure/Election of Directors or Officers
- Donald E. Bobo Jr. plans to retire by mid-2027 from Corporate Vice President, Strategy and Corporate Development
- Successor search begins promptly, with duties expected to transition during 2027
- Consulting arrangement through end-2027 supports continuity in strategy and corporate development functions
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Edwards Lifesciences 8-K filings
Get the next EW 8-K as it lands
Follow EW for push alerts, or ask the research agent what this filing means.